CRNX
STRONGCrinetics Pharmaceuticals, Inc.
CIK: 0001658247
Last activity: 2 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (7 total, 7 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Struthers Richard Scott
President & CEO
|
0 | 2 | -$822K |
413,563 shares
$15.35M
|
|
Betz Stephen F.
Chief Scientific Officer
|
0 | 2 | -$397K |
141,342 shares
$5.25M
|
|
Knight Jeff E.
Chief Operating Officer
|
0 | 2 | -$370K |
115,979 shares
$4.30M
|
|
Schilke Tobin
Chief Financial Officer
|
0 | 1 | -$266K |
78,121 shares
$3.10M
|
|
Vivaldi Coelho Rogerio
DIRECTOR
|
0 | 2 | -$181K |
16,823 shares
$607K
|
|
Kalofonos Isabel
Chief Commercial Officer
|
0 | 1 | -$138K |
834 shares
$46K
|
|
Okey Stephanie
DIRECTOR
|
0 | 1 | -$119K |
13,300 shares
$528K
|
Recent Transactions
13,196 shares @ $37.11
$490K
Mar 16, 2026
8,785 shares @ $37.77
$332K
Mar 16, 2026
6,371 shares @ $37.11
$236K
Mar 16, 2026
5,950 shares @ $37.11
$221K
Mar 16, 2026
4,241 shares @ $37.77
$160K
Mar 16, 2026
3,961 shares @ $37.77
$150K
Mar 16, 2026
4,477 shares @ $36.08
$162K
Mar 12, 2026
523 shares @ $36.77
$19K
Mar 12, 2026
6,713 shares @ $39.67
$266K
Mar 3, 2026
3,000 shares @ $39.67
$119K
Mar 3, 2026
2,500 shares @ $55.00
$138K
Jan 5, 2026
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.